TrialThe Lancet. Oncology2022

Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

Christine Mauz-Körholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.